Table 1.
Summary of epigenetic modifications in SSc.
Epigenetic process | Modification | Cell type | Effect | References |
---|---|---|---|---|
Global DNA methylation | ||||
↓ | Fibroblasts | Profibrotic | Altorok et al.25 | |
↓ | CD4+ T cells | Supposed increased expression of autoimmune-related genes in lymphocytes | Lei et al.34 | |
Skewed X chromosome inactivation | PBMCs | Immunosenescence, autoantibody production | Kanaan et al.43 | |
Ozbalkan et al.44 | ||||
Gene-specific DNA methylation | ||||
Fli1 | ↑ | Fibroblasts | Profibrotic | Wang et al.26 |
KLF5 | ↑ | Fibroblasts | Profibrotic | Noda et al.29 |
DKK1, SFRP1 | ↑ | Fibroblasts | Profibrotic | Dees et al.31 |
PARP1 | ↑ | Fibroblasts | Profibrotic | Zhang et al.32 |
IFN-related genes (IFI44L, IFITM1, MX1, PARP9) | ↓ | CD4+ and CD8+ T cells | Increased IFN production | Ding et al.35 |
Chen et al.36 | ||||
IRF7 | ↓ | PBMCs | N.D. | Rezaei et al.38 |
ITGAL | ↓ | CD4+ T cells | Increased proliferation of CD4+ T cells, IgG overproduction by B cells, and excessive collagen synthesis by fibroblasts | Wang et al.39 |
RUNX3 | ↑ | pDCs | Profibrotic | Affandi et al.40 |
BMPR2 | ↑ | MVECs | Proapoptotic | Wang and Kahaleh42 |
CD40L (X chromosome) | ↓ | CD4+ T cells | Altered immune response | Lian et al.45 |
ARX, HSFX1, IL1RAPL2 (X chromosome) | ↑ | PBMCs | Disease susceptibility | Selmi et al.46 |
ZBED1, ZNF41, PGMRC1 (X chromosome) | ↓ | PBMCs | Disease susceptibility | Selmi et al.46 |
FOXP3 (X chromosome) | ↑ | CD4+ T cells | Treg reduction | Wang et al.47 |
Global histone acetylation | ||||
↓ HDAC2, HDAC7 H4 hyperacetylation |
B cells | B cell dysfunction | Wang et al.48 | |
altered H3K4me3, H3K27ac |
Monocytes | Altered phenotype | Van der Kroef et al.49 | |
↑ HDAC5 | Endothelial cells | Impaired angiogenesis | Tsou et al.50 | |
↓ SIRT1, 3, 7 | Fibroblasts | Profibrotic | Chu et al.51 | |
Wyman et al.52 | ||||
Sosulski et al.53 | ||||
↑ p300 | Fibroblasts | Profibrotic | Ghosh et al.54 | |
Gene-specific histone acetylation | ||||
KLF5 | H3, H4 hypoacetylation | Fibroblasts | Profibrotic | Noda et al.29 |
FLI1 | H3, H4 hypoacetylation | Fibroblasts | Profibrotic | Noda et al.29 |
Wang et al.55 | ||||
Global histone methylation | ||||
↑ H3K27me3 ↑ EZH2 |
Fibroblasts, endothelial cells | Profibrotic, impaired angiogenesis | Xiao et al.56 | |
Tsou et al.57 | ||||
↑ H3K27me3 ↑ EZH2 |
Fibroblasts | Antifibrotic | Krämer et al.58 | |
↓ H3K27me3 ↑ JMJD3 |
CD4+ T cells | N.D. | Wang et al.59 | |
H3K9 hypomethylation ↓ SUV39H2 ↑ JHDM2 |
B cells | N.D. | Wang et al.48 | |
Gene-specific histone methylation | ||||
FOSL2 | ↓ H3K27me3 ↑ JMJD3 = UTX |
Fibroblasts | Profibrotic | Bergmann et al.60 |
PBMC, peripheral blood mononuclear cell; pDC, plasmacytoid dendritic cell: MVEC, microvascular endothelial cell; N.D., not determined; SSc, systemic sclerosis.